Filed: 11/14/2025ACC: 0001583977-25-000011
📋 What this filing means
CORMORANT ASSET MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 36 equity positions with a total reported market value of $1.45B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
36
Positions
$1.45B
Total AUM (reported)
73.81M
Total Shares
Allocation by class
COM$535.03M36.9%
COM NEW$472.88M32.6%
SPONSORED ADS$212.24M14.6%
ORDINARY SHARES$89.26M6.2%
COMMON STOCK$63.63M4.4%
COM PAR $.01$61.92M4.3%
CLASS A ORD$14.30M1.0%
Portfolio Concentration
Top 3$491.14M33.9%
4–10$484.24M33.4%
11–25$381.00M26.3%
Rest$92.88M6.4%
Top 3 weight
33.9%
Top 10 weight
67.3%
Voting Authority Distribution
Total shares with voting rights: 73.81M
Sole
Full voting authority
73.81M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other36
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings36
Rows:
BRIDGEBIO ONCOLOGY THERAPEUT
DFNDShares17.88M
TypeSH
Market value$207.03M
14.29%
Sole
17.88M
Shared
0.00
None
0.00
ABIVAX SA
DFNDShares1.95M
TypeSH
Market value$165.56M
11.42%
Sole
1.95M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
DFNDShares8.32M
TypeSH
Market value$118.55M
8.18%
Sole
8.32M
Shared
0.00
None
0.00
RAPPORT THERAPEUTICS INC
DFNDShares3.19M
TypeSH
Market value$94.82M
6.54%
Sole
3.19M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
DFNDShares1.40M
TypeSH
Market value$72.72M
5.02%
Sole
1.40M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
DFNDShares4.01M
TypeSH
Market value$65.04M
4.49%
Sole
4.01M
Shared
0.00
None
0.00
BRIGHT MINDS BIOSCIENCES INC
DFNDShares1.06M
TypeSH
Market value$64.26M
4.43%
Sole
1.06M
Shared
0.00
None
0.00
ARCELLX INC
DFNDShares775K
TypeSH
Market value$63.63M
4.39%
Sole
775K
Shared
0.00
None
0.00
INSMED INC
DFNDShares430K
TypeSH
Market value$61.92M
4.27%
Sole
430K
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
DFNDShares2.17M
TypeSH
Market value$61.86M
4.27%
Sole
2.17M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
DFNDShares1M
TypeSH
Market value$53.00M
3.66%
Sole
1M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
DFNDShares1.93M
TypeSH
Market value$46.68M
3.22%
Sole
1.93M
Shared
0.00
None
0.00
PHARVARIS N V
DFNDShares1.36M
TypeSH
Market value$34.01M
2.35%
Sole
1.36M
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
DFNDShares2.38M
TypeSH
Market value$30.04M
2.07%
Sole
2.38M
Shared
0.00
None
0.00
GH RESEARCH PLC
DFNDShares1.92M
TypeSH
Market value$27.41M
1.89%
Sole
1.92M
Shared
0.00
None
0.00
CG ONCOLOGY INC
DFNDShares625K
TypeSH
Market value$25.18M
1.74%
Sole
625K
Shared
0.00
None
0.00
KORRO BIO INC
DFNDShares465K
TypeSH
Market value$22.27M
1.54%
Sole
465K
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
DFNDShares1.23M
TypeSH
Market value$21.44M
1.48%
Sole
1.23M
Shared
0.00
None
0.00
METSERA INC
DFNDShares400K
TypeSH
Market value$20.93M
1.44%
Sole
400K
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
DFNDShares850K
TypeSH
Market value$20.77M
1.43%
Sole
850K
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
DFNDShares300K
TypeSH
Market value$17.83M
1.23%
Sole
300K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
DFNDShares400K
TypeSH
Market value$16.66M
1.15%
Sole
400K
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
DFNDShares2.32M
TypeSH
Market value$15.87M
1.10%
Sole
2.32M
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
DFNDShares775K
TypeSH
Market value$14.61M
1.01%
Sole
775K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares1.99M
TypeSH
Market value$14.30M
0.99%
Sole
1.99M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BRIDGEBIO ONCOLOGY THERAPEUTDFND | COM NEW | 17.88M | SH | $207.03M 14.29% | 17.88M | 0.00 | 0.00 |
ABIVAX SADFND | SPONSORED ADS | 1.95M | SH | $165.56M 11.42% | 1.95M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCDFND | COM NEW | 8.32M | SH | $118.55M 8.18% | 8.32M | 0.00 | 0.00 |
RAPPORT THERAPEUTICS INCDFND | COM | 3.19M | SH | $94.82M 6.54% | 3.19M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCDFND | COM | 1.40M | SH | $72.72M 5.02% | 1.40M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCDFND | COM | 4.01M | SH | $65.04M 4.49% | 4.01M | 0.00 | 0.00 |
BRIGHT MINDS BIOSCIENCES INCDFND | COM NEW | 1.06M | SH | $64.26M 4.43% | 1.06M | 0.00 | 0.00 |
ARCELLX INCDFND | COMMON STOCK | 775K | SH | $63.63M 4.39% | 775K | 0.00 | 0.00 |
INSMED INCDFND | COM PAR $.01 | 430K | SH | $61.92M 4.27% | 430K | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYDFND | ORDINARY SHARES | 2.17M | SH | $61.86M 4.27% | 2.17M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES IDFND | COM NEW | 1M | SH | $53.00M 3.66% | 1M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCDFND | SPONSORED ADS | 1.93M | SH | $46.68M 3.22% | 1.93M | 0.00 | 0.00 |
PHARVARIS N VDFND | COM | 1.36M | SH | $34.01M 2.35% | 1.36M | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSDFND | COM NEW | 2.38M | SH | $30.04M 2.07% | 2.38M | 0.00 | 0.00 |
GH RESEARCH PLCDFND | ORDINARY SHARES | 1.92M | SH | $27.41M 1.89% | 1.92M | 0.00 | 0.00 |
CG ONCOLOGY INCDFND | COM | 625K | SH | $25.18M 1.74% | 625K | 0.00 | 0.00 |
KORRO BIO INCDFND | COM | 465K | SH | $22.27M 1.54% | 465K | 0.00 | 0.00 |
MBX BIOSCIENCES INCDFND | COM | 1.23M | SH | $21.44M 1.48% | 1.23M | 0.00 | 0.00 |
METSERA INCDFND | COM | 400K | SH | $20.93M 1.44% | 400K | 0.00 | 0.00 |
JANUX THERAPEUTICS INCDFND | COM | 850K | SH | $20.77M 1.43% | 850K | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCDFND | COM | 300K | SH | $17.83M 1.23% | 300K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INDFND | COM | 400K | SH | $16.66M 1.15% | 400K | 0.00 | 0.00 |
ENGENE HOLDINGS INCDFND | COM | 2.32M | SH | $15.87M 1.10% | 2.32M | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCDFND | COM | 775K | SH | $14.61M 1.01% | 775K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 1.99M | SH | $14.30M 0.99% | 1.99M | 0.00 | 0.00 |
Page 1 of 2